Representing the Masses


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

Product Description

The life-sciences industry’s associations represent broad sectors and stakeholders varying from marketing to clinical as well as targeted segments such as businesswomen.
PharmaVOICE reached out to the CEOs, presidents, and chairs of the groups that represent the industry and asked these thought leaders to discuss the trends and challenges affecting their organizations’ membership, as well as how their groups can impact change in the coming years.
According to our Forum participants, common themes include the increasing globalization of the industry and issues related to outsourcing and distance education, as well as incorporating technology to better facilitate global cooperation. On the home front, the upcoming presidential election, patent protection concerns, and work toward universal healthcare are topics that are on everyone’s mind…

Face-to-Face-to-Face Leadership
Background on the Industry’s Backbone

Association Leaders
Thomas L. Adams is President, CEO, Secretary-Treasurer, of the Association of Clinical Research Professionals (ACRP), Alexandria, Va. He is active in a number of associations and has served as an officer and director of the American Association of Medical Society Executives. An association executive for most of his career, Mr. Adams served as Executive Director of the American Society of Plastic Surgeons, President of the Medical Group Management Association, and Executive VP of the Wisconsin Medical Society before joining ACRP in January 2001. He sits on the U.S. Secretary of Health and Human Services’ Advisory Committee on Human Research Protections. For more information, visit
Jonathan Andrus, MS, CQA, CCDM, is the incoming 2008 Chair of the Society for Clinical Data Management Inc. (SCDM), Milwaukee, Wis. Mr. Andrus also serves as VP, Clinical Data Management and Regulatory Operations, at Phoenix Data Systems Inc. where he manages regulatory compliance, data management, and training. Before joining PDS, Mr. Andrus managed clinical system validations and Part 11 and HIPAA assessments, and he conducted computer system audits with Taratec Development Corp. His other professional affiliations include the DIA, the American Society for Quality, and the Mid-Atlantic Region Society for Quality Assurance. Mr. Andrus is a frequent speaker on topics related to electronic data capture, quality assurance, and regulatory, and he is an instructor with the Pharmaceutical Training Institute. For more information, visit
Jay Bolling is President of the Healthcare Communication & Marketing Association Inc. (HCMA), Bethlehem, Pa. In addition, he serves as President of Roska Healthcare Advertising. Having overseen healthcare advertising programs for more than 20 years, Mr. Bolling is a recognized thought leader and innovator at the forefront of today’s pharmaceutical marketers. For more information, visit
Brian Fagan is Executive Director of The Society of Pharmaceutical and Biotech Trainers (SPBT), Roanoke, Va. Before joining SPBT, he spent 24 years in the pharmaceutical industry in sales leadership positions. For more information, visit
Ronald D. Fitzmartin, Ph.D., is President of the Board of Directors of the Drug Information Association (DIA), Horsham, Pa. In addition, Dr. Fitzmartin is VP, Informatics and Knowledge Management, at Daiichi Sankyo Pharma Development, the product development arm of the U.S. organization, engaged in clinical development, translational medicine and clinical pharmacology, regulatory affairs and risk management, informatics and knowledge management, biostatistics and data operations, and development research. He has held positions at Daiichi Medical Research, Purdue Pharma, the U.S. Census Bureau, the U.S. Department of the Navy, and the University of Maryland. For more information, visit
James C. Greenwood is President and CEO of the Biotechnology Industry Organization (BIO), Washington, D.C. Since his appointment in January 2005, he has markedly enhanced the trade association’s capacity — increasing both its staff and budget by almost 50%. He represented Pennsylvania’s Eighth District in the U.S. House of Representatives from January 1993 through January 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as a leader on healthcare and the environment. From 2001 to 2004, Mr. Greenwood served as Chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation with oversight authority over issues in the committee’s vast jurisdiction. Before his election to Congress, Mr. Greenwood served six years in the Pennsylvania General Assembly (1980-1986) and six years in the Pennsylvania Senate (1986-1993). For more information, visit
Mark B. Leahey, Esq., is the Executive Director of The Medical Device Manufacturers Association (MDMA), Washington, D.C. His responsibilities include advocating on behalf of the entrepreneurial sector of the medical-device industry to Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal agencies. Mr. Leahey lobbied for a more reasonable user fee for small companies, worked to open access to the hospital marketplace by challenging the exclusionary and anticompetitive nature of large group purchasing organizations (GPOs), as well as ensured that medical-device technology is reimbursed at adequate rates. Before his appointment to executive director in 2002, Mr. Leahey served as the association’s Director of Federal Affairs. For more information, visit
Elizabeth M. Mutisya, M.D., is the 2008 President of the Healthcare Businesswomen’s Association, Fairfield, N.J. Dr. Mutisya, who has held senior roles in the pharmaceutical industry, is currently a consultant at McKinsey & Company. For more information, visit
Douglas Peddicord, Ph.D., is Executive Director of The Association of Clinical Research Organizations (ACRO), Washington, D.C. Following a career as a clinical psychologist, he was an American Association for the Advancement of Science (AAAS) Fellow in the U.S. Congress in 1994-1995. Dr. Peddicord speaks frequently on the subject of the particular role of the CRO (along with the sponsor, investigator, IRB, and regulator) in the system that provides for the protection of human research participants, as well as on broader issues relating to the conduct of clinical research, including health information privacy, financial conflicts of interest, and the globalization of clinical trials. For more information, visit
Lynn Shapiro Snyder, Esq., is the Founder and President of the Women Business Leaders of the U.S. Health Care Industry Foundation (WBL). In addition to founding WBL, Ms. Snyder is a senior member in the Washington, D.C., office of the national law firm, Epstein Becker & Green, PC. She serves on the firm’s board and finance committee. She has almost 30 years of experience at the firm advising clients about federal, state, and international health law issues. For more information, visit
Billy Tauzin is President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, D.C., a post he assumed in January 2005 at which time he immediately took up two of the most important causes of his career: to help ensure patients everywhere continue to have access to medicines, and to ensure that innovative biopharmaceutical research thrives, improving and saving lives everywhere. He knows firsthand what patients face as they search for hope, treatment, and cures having recently battled cancer himself. Mr. Tauzin has a long and distinguished public service career, including 13 terms representing the people of the 3rd Congressional District of Louisiana. He began his public service career in the Louisiana State Legislature where he served in a variety of distinguished posts such as Chairman of the House Natural Resources Committee and Chief Administration Floor Leader. He was chosen twice as one of Louisiana’s Ten Best Legislators. He was first elected to the U.S. House in 1980 as a Democrat. Because his conservative views increasingly led him to vote with GOP House members despite his Democratic affiliation, he switched parties in 1995. In September 1995 he was named Deputy Majority Whip; he is the first American to have been part of the leadership of both parties in the House. In an effort to promote a spirit of bipartisan cooperation on Capitol Hill, he cofounded and served as Co-Chairman of the Mainstream Conservative Alliance, better known as Republican Blue Dogs. Until February, 2004, he served as the Chairman of the influential House Committee on Energy and Commerce. For more information, visit